Third Wave Drops HCV Suit Against Chiron, Bayer
Third Wave’s dispute with Stratagene Corp. over patent infringement is ongoing.
No licenses were granted or taken under the agreement, whose terms were not disclosed, and no payment was made to any of the companies, according to a Third Wave press release.
Third Wave initiated the litigation...
To view the full article, register now.